Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase NA 1 Phase 4 1 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 16 Stomach Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Nasopharyngeal Carcinoma 3 Carcinoma, Hepatocellular 3 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasm Metastasis 2 Nasopharyngeal Neoplasms 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Radiation Pneumonitis 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Non Squamous Non-small Cell Lung Cancer 1 Neoplasms 1 Neoplasm Recurrence, Local 1 Motor Activity 1 Gastric Cancer Stage 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 B-cell Malignancies 1 Advanced Squamous Non-Small Cell Lung Carcinoma 1 Advanced Squamous Non Small Cell Lung Cancer 1 Advanced Non-squamous Non-small-cell Lung Cancer 1

Interventions

Dexamethasone 28 Rituximab 16 pomalidomide 13 Gemcitabine 12 Lenalidomide 11 Cisplatin 11 Bortezomib 11 Paclitaxel 10 Cyclophosphamide 8 Carboplatin 8 carfilzomib 7 selinexor 5 daratumumab 5 Drug Therapy 5 Doxorubicin 5 Cytarabine 5 ibrutinib 4 Vincristine 4 Temozolomide 4 Prednisone 4 Docetaxel 4 Calcium Dobesilate 4 Bevacizumab 4 Aspirin 4 tisagenlecleucel 3 Cetuximab 3 Bendamustine Hydrochloride 3 venetoclax 2 ofatumumab 2 galiximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recurrence × tislelizumab × Clear all

NCT03924986 2025-01-31

RATIONALE-309

BeiGene

Phase 3 Completed

263 enrolled 19 charts

Nasopharyngeal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡